CL2007003333A1 -
PURIFIED HEMOCIANINE OBTAINED FROM F. LATIMARGINATA, F. CUMINGI OR F. MAXIMA; PURIFIED HEMOCIANINE SUBUNITY; USE OF HEMOCIANINE, ITS SUBUNITIES OR IMMUNOGENIC FRAGMENTS; AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH HEMOCIANINE OR ITS ITS
- Google Patents
PURIFIED HEMOCIANINE OBTAINED FROM F. LATIMARGINATA, F. CUMINGI OR F. MAXIMA; PURIFIED HEMOCIANINE SUBUNITY; USE OF HEMOCIANINE, ITS SUBUNITIES OR IMMUNOGENIC FRAGMENTS; AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH HEMOCIANINE OR ITS ITS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosonda S A 70 Y Fundacion CifiledCriticalBiosonda S A 70 Y Fundacion Ci
Priority to CL2007003333ApriorityCriticalpatent/CL2007003333A1/en
Publication of CL2007003333A1publicationCriticalpatent/CL2007003333A1/en
CL2007003333A2007-11-212007-11-21
PURIFIED HEMOCIANINE OBTAINED FROM F. LATIMARGINATA, F. CUMINGI OR F. MAXIMA; PURIFIED HEMOCIANINE SUBUNITY; USE OF HEMOCIANINE, ITS SUBUNITIES OR IMMUNOGENIC FRAGMENTS; AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH HEMOCIANINE OR ITS ITS
CL2007003333A1
(en)
PURIFIED HEMOCIANINE OBTAINED FROM F. LATIMARGINATA, F. CUMINGI OR F. MAXIMA; PURIFIED HEMOCIANINE SUBUNITY; USE OF HEMOCIANINE, ITS SUBUNITIES OR IMMUNOGENIC FRAGMENTS; AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH HEMOCIANINE OR ITS ITS
PURIFIED HEMOCIANINE OBTAINED FROM F. LATIMARGINATA, F. CUMINGI OR F. MAXIMA; PURIFIED HEMOCIANINE SUBUNITY; USE OF HEMOCIANINE, ITS SUBUNITIES OR IMMUNOGENIC FRAGMENTS; AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH HEMOCIANINE OR ITS ITS
PURIFIED HEMOCIANINE OBTAINED FROM F. LATIMARGINATA, F. CUMINGI OR F. MAXIMA; PURIFIED HEMOCIANINE SUBUNITY; USE OF HEMOCIANINE, ITS SUBUNITIES OR IMMUNOGENIC FRAGMENTS; AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH HEMOCIANINE OR ITS ITS
Substituted 1-cyanoethylheterocyclylcarboxamide derivative compounds, dipeptidylpeptidase i (dppi) or cathepsin c inhibitors; pharmaceutical composition; pharmaceutical combination; and its use in the treatment of asthma, chronic obstructive disease or allergic rhinitis.
COMPOUNDS DERIVED FROM SUBSTITUTED PYRIMIDINS; PROCESS FOR THE PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF Rheumatoid ARTHRITIS, ATEROSCLEROSIS, AMONG OTHER DISEASES
COMPOUNDS DERIVED FROM PIRAZOLILTIENOPIRIDINAS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE INHIBITION OF ESCARAS.
PHARMACEUTICAL COMPOSITION THAT INCLUDES 2- [6- (3-AMINO-PIPERIDIN-1-IL) -3-METIL-2,4-DIOXO-3,4-DIHIDRO-2H-PIRIMIDIN-1-ILMETIL] -4-FLUORO- BENZONITRILE; AND USE FOR THE TREATMENT OF DIABETES.
COMPOUNDS DERIVED FROM 2- (4 AMINO-PIRROLO-PIRIDIN) FURAN-3,4 DIOL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT AND / OR PREVENTION OF VIRAL INFECTIONS.
COMPOUNDS DERIVED FROM 5-HYDROXIMETHYL OXAZOLIDIN-2-ONA; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT AND PREVENT BACTERIAL INFECTIONS.
COMPOUNDS DERIVED FROM HETEROARIL-PIRROLIDINIL-CETONA AND HETEROARIL-PIPERIDINIL-CETONA; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DEPRESSION AND ANXIETY.